"Researchers of the University of Colorado examine Marijuana use and short-term outcomes in patients hospitalized for Acute Myocardial Infarction (AMI)"

There are known benefits of marijuana for the treatment of numerous medical conditions such as cancer, glaucoma, HIV / AIDS and post-traumatic stress disorder.

However, with increasing use, there is a worrying increase in reports of adverse cardiovascular events after marijuana exposure.



Based on the limited published data, authors hypothesized that marijuana use would be associated with worse in-hospital results in patients with Acute Myocardial Infarction (AMI).

Few studies, however, have examined the impact of marijuana use on cardiovascular outcomes such as AMI and are limited by small sample sizes but a study aimed at quantitating long-term effects for marijuana users after AMI showed no correlation between marijuana consumption and long-term mortality in patients after AMI.

The purpose of this retrospective study is to quantify short-term outcomes in AMI patients with reported marijuana use to those with no reported marijuana use. 
The researchers compared the results of AMI patients in the hospital with reported marijuana use to those who did not report marijuana use.
In total, 3,854 of 1,273,897 AMI patients reported using marijuana.

How to Read a CBD Lab Report (5 Easy Steps by CBDfx)

CBD lab reports are essential for discerning good products from bad, but how do you read these reports?    

If you’re rightfully concerned with product purity and integrity that matches what’s on the label, you might be asking yourself: can labs test for CBD? The answer is absolutely, and they do so all the time for reputable CBD manufacturers. With the CBD industry on the rise, the demand for accurate, reliable CBD lab reports is greater than ever before. Once you’ve gotten your hands on a CBD lab report, however, you’ll find that it includes a lot of information to unpack – and you might not be sure what it all means. In this guide, we’ll teach you how to accurately read CBD lab tests in five easy steps.

"Cannabidiol as a Potential Treatment for Anxiety Disorders

The purpose of the current review is to determine CBD’s potential as a treatment for anxiety-related disorders, by assessing evidence from preclinical, 
human experimental, clinical, and epidemiological studies. 





This review emphasizes the potential value and need for further study of CBD in the treatment of anxiety disorders.

Fear and anxiety are adaptive responses essential to coping with threats to survival. Yet excessive or persistent fear may be maladaptive, leading to disability. Symptoms arising from excessive fear and anxiety occur in a number of neuropsychiatric disorders, including generalized anxiety disorder (GAD), panic disorder (PD), post-traumatic stress disorder (PTSD), social anxiety disorder (SAD), and obsessive–compulsive disorder (OCD).

Notably, PTSD and OCD are no longer classified as anxiety disorders in the recent revision of the Diagnostic and Statistical Manual of Mental Disorders, however, excessive anxiety is central to the symptomatology of both disorders. These anxiety-related disorders are associated with a diminished sense of well-being, elevated rates of unemployment and relationship breakdown, and elevated suicide risk

Israeli Researchers Discover How And Why Autism Responds Well To Cannabis

Israeli scientists have discovered the reason why kids with autism 
respond so well to cannabis medications.
It’s because they have lower endogenous cannabinoid levels compared to matched controls.

The study, which was published in the medical journal Molecular Autism, involved analyzing the endocannabinoid serum rates among 93 patients with autism spectrum disorder (ASD) and compared them to controls. The researchers found that the children with ASD have “substantially lower” serum levels of anandamide, a primary endocannabinoid, as well as other compounds.

Israeli scientists have long been in the forefront of autism research, as well as other medical applications of cannabis. This has been a great help to the scientific community at large, who have found it challenging to gain a better understanding of autism among children. This condition spares no one, yet every autistic child is affected in a different way. For this reason, finding standard treatment options has been close to impossible. But cannabis is proving promising for autism.

What is CBCV (Cannabichromevarin)

Cannabichromevarin (CBCV) first came to limelight in 1975 when Thailand researchers at the University of Nagasaki isolated the compound from a cannabis plant. However, not much research has been conducted on the compound since its discovery.

Actually there is not much information to give concerning the properties of CBCV due to the restrictions on marijuana research. However, there is some knowledge that may be used to predict its effect on the human body.

The concentration of CBCV in cannabis plants is much lower compared to cannabidiol (CBD) and tetrahydrocannabinol (THC). CBCV is related to cannabichromene (CBC), a compound that appears in smaller amounts than the two major ones. The chemical structure of CBCV is similar to that of CBC but much shorter. CBCV can rightly be described as a propyl cannabinoid, meaning that its molecular structure contains a propyl chain. The molecular formula for this compound is C19H26O2.

CBC (Cannabichromene)

Cannabichromene (CBC),  is one of the cannabinoids that found in the Cannabis plant and is therefore a phytocannabinoid. 

It bears structural similarity to the other natural cannabinoids, including  tetrahydrocannabinol (THC), tetrahydrocannabivarin (THCV), cannabidiol (CBD), and cannabinol (CBN), among others.

CBC and its derivatives are as abundant as cannabinols in cannabis.It is not scheduled by the Convention on Psychotropic Substances.

Cannabichromene was discovered in 1966 by Gaoni and Mechoulam on one hand and almost simultaneously by Claussen on the other, although since then little research has been carried out on this cannabinoid, with THC and CBD being the protagonists of the majority of subsequent studies. 

However, as we will see below, today there is a growing body of evidence demonstrating the tremendous therapeutic potential of this cannabinoid, especially in combination with other compounds in what is often referred to as an "ensemble effect of cannabinoids".

"ECH announces plans to open first UK medical cannabis clinics"

European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions

The clinics, which will open this spring, will be the first in the UK to offer cannabis-based therapy and prescription cannabiniods to patients suffering from chronic pain conditions including arthritis, fibromyalgia, nerve conditions, muscle cramps (spasticity); treating neurological conditions such as epilepsy, multiple sclerosis, Alzheimer’s and Parkinson’s disease; and addressing psychiatric problems such as depression, anxiety and post-traumatic stress disorder (PTSD).

The first clinic will open at The Beeches Consulting Centre in Manchester in March and will be led by Dr David McDowell, a Consultant in Pain Management who issued the first prescription for medical cannabis in December.

Clinics will then open in London across multiple disciplines including neurology and psychiatry in addition to chronic pain, on Harley Street, and in Birmingham later this spring.

Woman killed by 'THC overdose' in US, coroner claims...???

According to an article on Independent.co.uk, a US coroner has stood by his conclusion that a woman died of an overdose of THC...

So lets see what exactly says the article... Is this true or some people still hunting witches...????

In what would ostensibly be the first confirmed case in the country, coroner Dr Christy Montegut, of St John the Baptist Parish in Louisiana, said an unnamed 39-year-old woman died in February after vaping THC oil. 

“It looked like it was all THC because her autopsy showed no physical disease or afflictions that were the cause of death. There was nothing else identified in the toxicology — no other drugs, no alcohol. There was nothing else,” Dr Montegut told the New Orleans Advocate newspaper last month. 

CBGA (Cannabigerolic Acid)

 "The stem cell of cannabis"

Cannabigerolic acid is one of the many phytocannabinoids within the cannabis plant. Many phytocannabinoids  have acidic precursors.

To recap really quickly,  these acidic precursors  
turn into a subsequent cannabinoid through a process known as decarboxylation.  


Decarboxylation happens through various forms of heat application and is a fancy science word for when something loses a molecule of carbon dioxide. This heat application can include solar heat or directly applied heat as with cooking or smoking.  

But what makes cannabigerolic acid (CBGa) so special? Is it not just another acidic precursor? Aside from being a precursor for cannabigerol, it is also the precursor for a handful of other acidic precursors including THCA, CBDA and CBCA. It is crucial in creating common cannabinoids like CBC and THC. This is why some cannabis enthusiasts refer to it as the “stem cell” of cannabis, given its transformative nature.

CBN (Cannabinol)

Cannabinol (CBN) is a cannabinoid found in the Cannabis sativa plant, so it is part of the phytocannabinoids family, just like cannabidiol (CBD) and tetrahydrocannabinol (THC).

As its name suggests, CBN is related to THC, the compound being in fact a metabolite of tetrahydrocannabinol. This means that cannabinol is obtained from THC, through a process that involves both natural and special treatments.

Unlike other cannabinoids, CBN does not stem directly from cannabigerol (CBG) or cannabigerolic acid (CBGA), but rather is the degraded product of tetrahydrocannabinolic acid (THCA).If cannabis is exposed to air or ultraviolet light (for example, in sunlight) for a prolonged period of time, THCA will convert to cannabinolic acid (CBNA). CBN is then formed by decarboxylation of CBNA.

“Thanks To Cannabis Ava Is Pharma-Free.”

Vera Twomey is the mother of Ava, a little girl who developed Dravet’s Syndrome at four months old. For the first seven years of her life, Ava suffered up to 400 seizures a month until 2016 when Vera turned to cannabis for help. That decision changed their lives. Today, Ava is “pharma-free.”

-Ava’s Story: A Sick Child Saved by Cannabis

Nine years ago, Ava Barry was born a happy healthy baby girl, but at around four months she began to have seizures. Her terrified parents immediately brought her to their local hospital in Cork, south of Ireland, where the doctors began the process of trying to figure out what was wrong while simultaneously prescribing a mix of liquid medications to control the seizures, which could last up to 45 minutes.